Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Fei Zhou, Bao-Feng Liu, Can Wang, Jie Zhang, Guo-Ming Dong, Hong-Tao Jin, Bai-Ping Ma & Xiao-Ming Zhong. (2022) Acute toxicity, 28-day repeated-dose toxicity and toxicokinetic study of timosaponin BII in beagle dogs. Journal of Asian Natural Products Research 24:9, pages 860-876.
Read now
Read now
Arthur G Roberts & Morgan E Gibbs. (2018) Mechanisms and the clinical relevance of complex drug–drug interactions. Clinical Pharmacology: Advances and Applications 10, pages 123-134.
Read now
Read now
Neelima Ayyalasomayajula & Challa Suresh. (2018) Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer’s and neurodegenerative diseases. Nutritional Neuroscience 21:10, pages 682-694.
Read now
Read now
Sıla Gülbağ, Duygu Yılmaz Usta, Hazal E. Gültekin, Ayşe N. Oktay, Özden Demirtaş, Alptuğ Karaküçük & Nevin Çelebi. (2018) New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system. Pharmaceutical Development and Technology 23:5, pages 512-519.
Read now
Read now
Jerry J Flores, Yang Zhang, Damon W Klebe, Tim Lekic, Weiling Fu & John H Zhang. (2014) Small molecule inhibitors in the treatment of cerebral ischemia. Expert Opinion on Pharmacotherapy 15:5, pages 659-680.
Read now
Read now
Francesco Patti. (2012) Treatment of cognitive impairment in patients with multiple sclerosis. Expert Opinion on Investigational Drugs 21:11, pages 1679-1699.
Read now
Read now
Indrapal Singh & George T Grossberg. (2011) Critical appraisal and role of memantine extended-release in the management of Alzheimer’s disease. Degenerative Neurological and Neuromuscular Disease 1, pages 9-13.
Read now
Read now
Daphne Lo & George T Grossberg. (2011) Use of memantine for the treatment of dementia. Expert Review of Neurotherapeutics 11:10, pages 1359-1370.
Read now
Read now
Cesare Mancuso, Raffaella Siciliano, Eugenio Barone, David Allan Butterfield & Paolo Preziosi. (2011) Pharmacologists and Alzheimer disease therapy: to boldly go where no scientist has gone before. Expert Opinion on Investigational Drugs 20:9, pages 1243-1261.
Read now
Read now
Nathan Herrmann, Abby Li & Krista Lanctôt. (2011) Memantine in dementia: a review of the current evidence. Expert Opinion on Pharmacotherapy 12:5, pages 787-800.
Read now
Read now
Nazem Bassil, Papan Thaipisuttikul & George T Grossberg. (2010) Memantine ER, a once-daily formulation for the treatment of Alzheimer's disease. Expert Opinion on Pharmacotherapy 11:10, pages 1765-1771.
Read now
Read now
Articles from other publishers (21)
Chencheng Ye. (2023) Mechanism and efficacy of drugs for Alzheimer's disease. Highlights in Science, Engineering and Technology 36, pages 786-791.
Crossref
Crossref
Amanda Brignell, Catherine Marraffa, Katrina Williams & Tamara May. (2022) Memantine for autism spectrum disorder. Cochrane Database of Systematic Reviews 2022:8.
Crossref
Crossref
Caitlyn J. Bartsch & Jacob C. Nordman. (2022) Promises and Pitfalls of NMDA Receptor Antagonists in Treating Violent Aggression. Frontiers in Behavioral Neuroscience 16.
Crossref
Crossref
N. N. Koberskaya. (2022) Neuropsychiatric disorders correction in Alzheimer's disease. Neurology, Neuropsychiatry, Psychosomatics 14:3, pages 54-61.
Crossref
Crossref
Mahdieh Anoush, Zeinab Pourmansouri, Rafi Javadi, Benyamin GhorbanPour, Ali Sharafi, Hamed Mohamadpour, Iraj jafari anarkooli & Sina Andalib. (2022) Clavulanic Acid: A Novel Potential Agent in Prevention and Treatment of Scopolamine-Induced Alzheimer’s Disease. ACS Omega 7:16, pages 13861-13869.
Crossref
Crossref
Aylin Yaman & Hakan Yaman. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
2665
2675
.
Peyton H Terry, Kareem Seoudy, Meredith S Lee & Keri A Stevenson. (2021) Memantine for the Treatment of Behavioral Disturbance in Unspecified Major Neurocognitive Disorder. Cureus.
Crossref
Crossref
Anya Jafari, Zahra Siavashpour & Mohammad Houshyari. (2021) An Updated Review on Memantine Efficacy in Reducing Cognitive Dysfunction of Whole-brain Irradiation for Adult Patients with Brain metastasis. International Journal of Cancer Management 14:4.
Crossref
Crossref
Amanda Brignell, Chidambaram Prakash, Catherine Marraffa, Katrina Williams & Tamara May. (2021) Memantine for autism spectrum disorder. Cochrane Database of Systematic Reviews.
Crossref
Crossref
A.N. Bogolepova, E.E. Vasenina, N.A. Gomzyakova, E.I. Gusev, N.G. Dudchenko, A.Yu. Emelin, N.M. Zalutskaya, R.I. Isaev, Yu.V. Kotovskaya, O.S. Levin, I.V. Litvinenko, V.Yu. Lobzin, M.Yu. Martynov, E.A. Mkhitaryan, G.N. Nikolay, E.I. Palchikova, O.N. Tkacheva, M.A. Cherdak, A.S. Chimagomedova & N.N. Yakhno. (2021) Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:10, pages 6.
Crossref
Crossref
Aylin Yaman & Hakan Yaman. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
11
.
Jogender Mehla, Pooja Gupta, Monika Pahuja, Deepti Diwan & Diksha Diksha. (2020) Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment. Brain Sciences 10:12, pages 964.
Crossref
Crossref
Veronika Prikhodko, Daria Chernyuk, Yurii Sysoev, Nikita Zernov, Sergey Okovityi & Elena Popugaeva. (2020) Potential Drug Candidates to Treat TRPC6 Channel Deficiencies in the Pathophysiology of Alzheimer’s Disease and Brain Ischemia. Cells 9:11, pages 2351.
Crossref
Crossref
Yasuteru Inoue, Mitsuharu Ueda, Teruaki Masuda, Yohei Misumi, Taro Yamashita & Yukio Ando. (2019) Memantine, a Noncompetitive N-Methyl-d-Aspartate Receptor Antagonist, Attenuates Cerebral Amyloid Angiopathy by Increasing Insulin-Degrading Enzyme Expression. Molecular Neurobiology 56:12, pages 8573-8588.
Crossref
Crossref
I. S. Preobrazhenskaya, D. Fantalis, S. A. Abdyshova & A. A. Kindarova. (2019) Non-drug therapies for cognitive impairment. Neurology, Neuropsychiatry, Psychosomatics 11:3S, pages 68-77.
Crossref
Crossref
A. A. Naumenko & I. S. Preobrazhenskaya. (2018) Cognitive and motor training for patients with moderate cognitive impairment and mild dementia. Neurology, Neuropsychiatry, Psychosomatics 10:4, pages 81-87.
Crossref
Crossref
Shahrina Alam, Kaelyn Skye Lingenfelter, Aaron M. Bender & Craig W. Lindsley. (2017) Classics in Chemical Neuroscience: Memantine. ACS Chemical Neuroscience 8:9, pages 1823-1829.
Crossref
Crossref
Evan P. Lebois, Jason P. Schroeder, Thomas J. Esparza, Thomas M. Bridges, Craig W. Lindsley, P. Jeffrey Conn, David L. Brody, J. Scott Daniels & Allan I. Levey. (2017)
Disease-Modifying Effects of M
1
Muscarinic Acetylcholine Receptor Activation in an Alzheimer’s Disease Mouse Model
. ACS Chemical Neuroscience 8:6, pages 1177-1187.
Crossref
Crossref
Kimberly D. Girling & Yu Tian Wang. (2016) Neuroprotective strategies for NMDAR-mediated excitotoxicity in Huntington’s Disease. Frontiers in Biology 11:6, pages 439-458.
Crossref
Crossref
Theresa Lowinus, Tanima Bose, Stefan Busse, Mandy Busse, Dirk Reinhold, Burkhart Schraven & Ursula H.H. Bommhardt. (2016) Immunomodulation by memantine in therapy of Alzheimer's disease is mediated through inhibition of Kv1.3 channels and T cell responsiveness. Oncotarget 7:33, pages 53797-53807.
Crossref
Crossref
Alla Guekht. 2016. Neuropsychiatric Symptoms of Epilepsy. Neuropsychiatric Symptoms of Epilepsy
235
254
.